Related Experiment Video

Updated: May 12, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

microRNAs as pharmacological targets in cancer

Aroa Soriano1, Luz Jubierre, Ana Almazán-Moga

  • 1Laboratory of Translational Research in Childhood Cancer, Vall d'Hebron Institut de Recerca, Universitat Autónoma de Barcelona, Spain.

Pharmacological Research
|March 30, 2013
PubMed

Insights

MicroRNAs (miRNAs) offer a promising new avenue for cancer treatment by targeting multiple genes simultaneously. This approach aims to overcome challenges like metastasis and therapy resistance, improving patient survival rates.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Cancer patient survival has improved due to advances in prevention, early detection, and therapies.
  • Metastasis and acquired resistance to existing treatments remain significant hurdles for long-term cancer cure.
  • Novel therapeutic strategies are essential to address these persistent challenges in cancer treatment.

Purpose of the Study:

  • To review the mechanisms of microRNA (miRNA) deregulation in cancer.
  • To assess the therapeutic potential of miRNAs as a novel cancer treatment strategy.
  • To discuss various approaches for the pharmacological manipulation of miRNAs in preclinical cancer models.

Main Methods:

  • Literature review of epigenetic-based therapies, focusing on miRNAs.
  • Analysis of miRNA biogenesis and function in cancer gene regulation.
  • Examination of preclinical studies involving miRNA-targeted cancer therapies.

Main Results:

  • MicroRNAs are small non-coding RNAs that regulate gene expression and are frequently deregulated in cancer.
  • miRNAs can target multiple genes within the same or different pathways, potentially reducing treatment resistance.
  • Pharmacological strategies for miRNA manipulation show promise in preclinical cancer models.

Conclusions:

  • Epigenetic therapies, particularly those involving miRNAs, represent a promising frontier in cancer treatment.
  • The ability of miRNAs to regulate multiple targets offers a potential advantage over conventional therapies in overcoming resistance.
  • Further research and development of miRNA-based therapeutics are warranted for improved cancer patient outcomes.
Keywords:
AntimirsCancer therapymiRNA mimeticsmicroRNA

More Related Videos

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...